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Although it is believed that neural activation can
affect immune responses, very little is known about
the neuroimmune interactions involved, especially
the regulators of immune traffic across the blood-
brain barrier which occurs in neuroimmune diseases
such as multiple sclerosis (MS). Using a mouse
model of MS, experimental autoimmune encephalo-
myelitis, we show that autoreactive T cells access
the central nervous system via the fifth lumbar spinal
cord. This location is defined by IL-6 amplifier-
dependent upregulation of the chemokine CCL20 in
associated dorsal blood vessels, which in turn
depends on gravity-induced activation of sensory
neurons by the soleus muscle in the leg. Impairing
soleus muscle contraction by tail suspension is suffi-
cient to reduce localized chemokine expression and
block entry of pathogenic T cells at the fifth lumbar
cord, suggesting that regional neuroimmune interac-
tions may offer therapeutic targets for a variety of
neurological diseases.
INTRODUCTION
Neuroimmune interactions arise from at least two types of path-
ways (Felten, 2000; Sternberg, 2006; Thayer and Sternberg,
2010; Watkins and Maier, 1999): neurohormonal pathways that
depend on circulating hormones such as cortisol and catechol-amines including norepinephrine, and neural pathways that are
mainly mediated by direct neural connections with lymphoid
organs like the thymus, bone marrow, spleen, and lymph nodes.
Detailed anatomical analysis has suggested the lymphoid
organs are innervated by the peripheral nervous system
(Sternberg, 2006), the sympathetic nervous system (Nance and
Sanders, 2007), and the parasympathetic nervous system
(Tracey, 2007). Thus, neurohormonal pathways likely regulate
immune responses systemically, while neural pathways regulate
immune responses at a local and regional level, resulting in
regional property differences even within the same organ.
Although the systemic effects of neurohormonal pathways
have been well investigated, little is known about the mecha-
nisms used by the local neural pathways.
The central nervous system (CNS) is an immune-privileged
environment, protected by the blood-brain barrier, which is
formed by specific vessels tightly attached to each other (Galea
et al., 2007; Wilson et al., 2010). This barrier, however, can be
compromised upon the invasion of certain pathogens and/or
latent infections (McGavern and Kang, 2011; Salinas et al.,
2010), suggesting that immune cells in the peripheral lymphoid
organs contribute to CNS related immune responses. However,
how these cells enter and/or accumulate in the CNS from periph-
eral lymphoid organs is unclear. Moreover, although pathogenic
CD4+ T cells, which express high levels of cytokines such as
IL-17A and IFNg and include autoreactive cells in peripheral
lymphoid organs, are believed to play an essential role in the
pathogenesis of MHC class II-associated autoimmune diseases
like multiple sclerosis (MS) (Reboldi et al., 2009; Wilson et al.,
2010), the initial gates of entry through the blood-brain barrier
have yet to be analyzed, particularly at the molecular level. It isCell 148, 447–457, February 3, 2012 ª2012 Elsevier Inc. 447
known that leukocytes like CD4+ T cells migrate into the CNS
through the choroid plexus and subarachnoid space, brain
regions that show excess chemokine levels, including the
CCL20 chemokine, specifically in late phases of disease devel-
opment, suggesting that pathogenic CD4+ T cells can migrate
from the blood directly into the brain tissues during these phases
(Ransohoff, 2009; Reboldi et al., 2009; Wilson et al., 2010).
Further, it has been hypothesized that barrier properties and/or
the vasculature itself differ between CNS compartments and
that these differences may influence immune cell access (Wilson
et al., 2010). We hypothesize that these differences may arise
from regional neural activation around the vessels, such that
regional neural activation can regulate immune cell/blood cell
accumulation in the CNS.
An important mediator for this regulation may be the NFkB-
triggered positive-feedback-loop for IL-6 expression (IL-6 ampli-
fier) in endothelial cells, which line blood and lymphatic vessels.
We previously showed that this feedback loop is a synergistic
activator of NFkB and STAT3 in type 1 collagen+ cells after
IL-17A and IL-6 stimulation. Activation of the IL-6 amplifier can
lead to excess expression of various chemokines and cytokines
including CCL20 and IL-6 and the development of autoimmune
diseases like F759 arthritis and experimental autoimmune
encephalomyelitis (EAE), which is a multiple sclerosis model
induced by a myelin oligodendrocyte glycoprotein (MOG)-
derived autopeptide immunization (Hirano, 2010; Murakami
et al., 2011; Ogura et al., 2008). Additionally, those reports found
that IL-6 amplifier activation in mouse joints directly or indirectly
causes accumulation of various immune cell/blood cell popula-
tions including IL-17A- and IFNg-expressing pathogenic CD4+
T cells there. Knowing this, we examined whether endothelial
cell stimulation that depends on neural activity can trigger the
IL-6 amplifier to cause regional pathogenic CD4+ T cell migration
into the CNS. We demonstrate that regional neural activation
defines a gateway for autoreactive T cells to cross the blood-
brain barrier via the IL-6 amplifier activation in endothelial cells
at the fifth lumbar cord.
RESULTS
Transfused Pathogenic CD4+ T Cells Mainly Migrate
to the CNS via the Fifth Lumbar Cord during the Early
Stages of Autoimmune Disease Development
To discover the gates of entry into the CNS for immune cells
including pathogenic CD4+ T cells, we employed a passive
transfer method for EAE induction as described previously
(Ogura et al., 2008). Pathogenic CD4+ T cells were isolated
from wild-type C57BL/6 mice immunized with a MOG peptide
plus adjuvants (see the Experimental Procedures) and then
cultured in vitro with bone marrow-derived dendritic cells in the
presence of the same MOG peptide plus IL-23. The resulting
pathogenic CD4+ T cells contained Th1 and Th17 cells and
were intravenously transferred into wild-type C57BL/6 mice.
EAE development peaked at about 10–12 days after the transfer
(Figure S1A available online).
It has been reported pathogenic CD4+ T cells accumulate in
the choroid plexus from day 13 after EAE induction by systemic
immunizations in C57BL/6 mice (Reboldi et al., 2009). We found448 Cell 148, 447–457, February 3, 2012 ª2012 Elsevier Inc.no T cell accumulation around the choroid plexus during the first
5 days after pathogenic CD4+ T cell transfer in untreated mice
(data not shown). Because we have observed that pathogenic
T cells mainly accumulate in the spinal cord around day 10 of
EAE development (Sawa et al., 2009), we hypothesized that
pathogenic CD4+ T cells do not directly migrate to the choroid
plexus, but may accumulate in the spinal cord instead, making
the spinal cord a candidate for the gate in our model. We there-
fore investigated CD4+ T cell numbers in the spinal cord over first
5 days. We first investigated pathogenic CD4+ T cell accumula-
tion in the CNS by using anterior-posterior whole mount sections
after the transfer, finding robust pathogenic CD4+ T cell accu-
mulation in the lumbar level, but not in the thoracic and cervical
levels of the spinal cord (data not shown). We then analyzed the
lumbar level in detail. Because more than 95% of accumulated
mononuclear cells merged with a congenic marker having path-
ogenic CD4+ T cells, we measured pathogenic CD4+ T cells
by counting mononuclear cell numbers in five different spinal
sections (see Figure 1A legend), took the average and then
calculated the relative number of pathogenic CD4+ T cells,
finding a significant accumulation of pathogenic CD4+ T cells
in the fifth lumbar cord (Figure 1A), a result confirmed by flow
cytometry (Figure 1B). The accumulation was much greater in
the dorsal blood vessels of the fifth spinal cord than in the ventral
ones (Figure 1C), suggesting dorsal blood vessels of the fifth
spinal cord may be the gate to the CNS.
Activation of the IL-6 Amplifier Plays a Role
in the Accumulation of Pathogenic CD4+ T Cells
in the Fifth Lumbar Cord
Because pathogenic CD4+ T cell transfers included both Th1
and Th17 cells (Ogura et al., 2008) (data not shown), we next
investigated whether cytokines from these pathogenic CD4+
T cells contribute to the CD4+ T cell accumulation in the fifth
lumbar cord. For this purpose, we employed IFNg-deficient
and IL-17A-deficient mice and immunized them with the MOG
peptide plus CFA to obtain pathogenic CD4+ T cells lacking
IFNg or IL-17A. We then transferred these pathogenic CD4+
T cells separately into wild-type C57BL/6 mice to investigate
T cell migration. Of these, only pathogenic CD4+ T cells from
IFNg-deficient mice showed an accumulation in the fifth lumbar
cord like that seen in normal pathogenic CD4+ T cells (Figure 2A),
suggesting a role for IL-17A.
We have previously shown that Th17 cells accumulate in joints
in a manner dependent on activating the IL-6 amplifier (Mura-
kami et al., 2011), suggesting that the amplifier might be involved
in the above accumulation. Pathogenic CD4+ T cells were intra-
venously transferred into mutant mice deficient of IL-6 or of
either gp130 or STAT3 in their type 1 collagen+ cells and into
wild-type C57BL/6 mice. Pathogenic CD4+ T cell accumulation
was significantly suppressed in all mutant hosts (Figure 2B), sug-
gesting that, indeed, IL-6 amplifier activation was involved. We
also found the clinical EAE scores in these mutant mice to be
significantly suppressed (data not shown) and the IL-6 concen-
trations in serum to have decreased (Figure 2C). We next identi-
fied important type 1 collagen+ cell populations for pathogenic
CD4+ T cell accumulation in the fifth lumbar cord, because these
cell populations include fibroblasts, endothelial cells, epithelial
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Figure 1. Pathogenic CD4+ T Cells Transferred
to the Blood Mainly Migrate to the CNS from the
Fifth Lumbar Cord during the Early Stages of EAE
Development
(A) Pathogenic CD4+ T cell numbers in each spinal cord.
Pathogenic CD4+ T cells prepared from wild-type mice
transferred into wild-type hosts. The numbers of accu-
mulated pathogenic CD4+ T cells in the six lumber cords
were evaluated by counting mononuclear cells in six
different spinal sections (anterior-terminal, middle ante-
rior-center, center, middle center-posterior, and posterior-
terminal) and taking the average. Accumulated mono-
nuclear cells in the fifth lumber cord increased comparing
to other cords.
(B) Flow cytometry of mononuclear cells isolated from
each spinal lumbar cord. CD4+CD90.2+ cell numbers in
the fifth lumber cord increased comparing to other cords.
(C) Pathogenic CD4+ T cells isolated from EAE mice were
intravenously transferred into wild-type C57BL/6 mice.
Accumulation of pathogenic CD4+ T cells in the choroid
plexus and each spinal cord were observed in frozen
sections taken 5 days after the transfer. Left: Histological
analysis was performed with sections stained with hema-
toxylin-eosin in the central region of the fifth lumber cord.
Representative data are shown. The scale bar represents
100 mm. Top right: Magnification of black rectangle. The
scale bar represents 100 mm. Bottom right: 3D picture
based on ten serial HE sections of the fifth lumber cord
central region. Purple balls indicate nucleuses of patho-
genic CD4+ T cell nuclei; red tubes, vessels on the fifth
spinal cord.
Error bars represent the mean ± SEM. **p < 0.01. See also
Figures S1 and S5.cells, astrocytes, and activated neuron cells. Pathogenic CD4+
T cells were also transferred into mutant mice with Tie2+ endo-
thelial cells deficient of gp130 and into wild-type C57BL/6
mice. Pathogenic CD4+ T cell accumulation and clinical EAE
scores were significantly suppressed in these mutant hosts
(Figures S1B and S1C), suggesting the importance of type 1
collagen+ endothelial cells in the accumulation of pathogenic
CD4+ T cell in the fifth lumbar cord.
Consistent with these results, STAT3 activation was enhanced
in the endothelial cells of dorsal blood vessels in the fifth lumbar
cord, but neither in the fourth nor sixth lumbar cords, as deter-
mined by STAT3 phosphorylation levels (Figure 2D). These
results indicate IL-6 amplifier activation in endothelial cells has
a significant role in pathogenic CD4+ T cell accumulation in the
fifth lumbar cord during EAE development.
CCL20 Expression Contributes to the Accumulation
of Pathogenic CD4+ T Cells in the Fifth Lumbar Cord
We next attempted to identify a critical target molecule for
STAT3 and NFkB activation in type 1 collagen+ endothelial
cells during IL-6 amplifier activation. We considered chemo-
kines like CCL20, because they are synergistically expressed
via STAT3 and NFkB in type 1 collagen+ cells, are critical for
Th17 cell accumulation in an arthritis model (Murakami et al.,
2011), and because pathogenic CD4+ T cells from mice defi-
cient of CCR6, a CCL20 receptor, showed minimal accumula-
tion in the fifth lumbar cord (Figure S2A). We found that
CCL20 expression in the dorsal blood vessels of the fifthlumbar cord increased even in the absence of pathogenic
CD4+ T cell transfer (Figure 3A), with no such concomitant
effect in vessels of the thoracic and cervical cords (Figure S2B).
Interestingly, CCL20 expression eventually reached other
regions like the anterior lumbar cords after pathogenic CD4+
T cell transfer (Figure S2C, right), suggesting that the blood-
brain barrier is compromised broad regions after pathogenic
T cell accumulation in the CNS. Furthermore, along with
CCL20, chemokines such as CCL2, CCL3, CCL9, CCL21,
CCL24, CX3CL1, CXCL1, CXCL2, CXCL9, and CXCL11
increased in the dorsal blood vessels of the fifth lumbar cord
compared to the first lumbar cord (Figures 3A and 3B), while
anti-CCL20 antibody treatment in vivo significantly suppressed
pathogenic CD4+ T cell accumulation and the development of
EAE (Figures 3C– 3E).
We next investigated for correlations between CCL20
expression and IL-6 amplifier activation in the fifth lumbar
cord. Again, mutant mice deficient of IL-6 or of either gp130
or STAT3 in their type 1 collagen+ cells were employed.
CCL20 messenger RNA (mRNA) expressions in the dorsal
blood vessels of the fifth lumbar cord was less in all three
mutant recipients than in wild-types (Figure 3F). Together with
the importance of IL-17A and CCR6 expression in pathogenic
CD4+ T cells, these results suggest that CCL20 expression,
which is known to be regulated by IL-6 amplifier activation, at
least in joints, plays a similar role in pathogenic CD4+ T cell
accumulation in the fifth lumbar cord and that this leads to
EAE development.Cell 148, 447–457, February 3, 2012 ª2012 Elsevier Inc. 449
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Figure 2. Activation of IL-6-Mediated Amplification
Plays a Role in Pathogenic CD4+ T Cell Accumula-
tion in the Fifth Lumbar Cord
(A) Pathogenic CD4+ T cells prepared from IL17A-defi-
cient, IFNg-deficient, or wild-type mice were transferred
into wild-type hosts. Relative numbers of accumulated
pathogenic CD4+ T cells in the fifth lumber cord. Accu-
mulated mononuclear cells in the fifth lumber cord
decreased after transfer of IL-17A-deficient T cells
comparing to that of wild-type ones.
(B) Pathogenic CD4+ T cells prepared from wild-type mice
were transferred into mutant hosts deficient of IL-6 or of
either gp130 or STAT3 in their type 1 collagen+ cells.
Relative numbers of accumulated pathogenic CD4+
T cells in the fifth lumbar cord.
(C) Serum IL-6 concentrations in the mutant hosts
described in (B). Serum IL-6 decreased in all mutant mice
comparing to wild-type ones.
(D) Top: Histological analysis was performed with frozen
sections stained with anti-phospho-STAT3 antibody or
control rabbit IgG plus secondary antibody. The fourth,
fifth, and sixth lumber cords are shown. Arrows indicate
endothelial cell nuclei in the dorsal blood vessels of each
lumber cord. Scale bars represent 50 mm. Bottom: Quan-
tification of the histological analysis (n = 300 cells for each
lumbar cord). Phospho-STAT3+ endothelial cell numbers
increased in the fifth lumber cords comparing to the fourth
and sixth ones.
Error bars represent the mean ± SEM, **p < 0.01 (A)–(C).
Error bars represent the mean ± SD (D), **p < 0.01. See
also Figure S1.Sensory Nerve Activation via Soleus Muscles Is Critical
for CCL20 Expression in the Fifth Lumbar Cord and the
Ensuing Pathogenic CD4+ T Cell Accumulation
We then considered how the IL-6 amplifier in dorsal blood
vessels of the fifth lumbar cord is activated to express CCL20
prior to pathogenic CD4+ T cell transfer. We focused on the acti-
vation of soleus muscle-mediated sensory nerves, because their
dorsal root ganglia locate near the fifth lumbar (Ohira et al., 2004).
We hypothesized that frequent stimulation of the soleus muscles
in response to a gravitational stimulus could induce activation of
the IL-6 amplifier via their sensory nerves, which in turn would
directly or indirectly induce high CCL20 expression in the blood
vessels of the fifth lumbar cord. For this, we employed a tail
suspension model, which is a widely accepted National Aero-
nautics and Space Administration ground-based model for
studying disuse-atrophy in rodents to eliminate any response
by the hind legs to the stimulus (Canu and Garnier, 2009;
De-Doncker et al., 2005; Kawano et al., 2007; Nakao et al.,
2009). Tail suspensions significantly decreased CCL20 expres-
sion in dorsal blood vessels of the fifth lumbar cord (see the
left two columns in Figure 4A). Consistent with this, tail suspen-
sions also significantly suppressed pathogenic CD4+ T cell
accumulation in the fifth lumbar cord (Figure 4B), while patho-
genic CD4+ T cell accumulation and CCL20 expression in
cervical cord blood vessels increased, especially in the posterior
side (Figure 4B and Figure S3A). Moreover, c-fos expression
levels decreased in fifth dorsal root ganglia (Figure 4C), but
increased in the dorsal root ganglia of the cervical spine after450 Cell 148, 447–457, February 3, 2012 ª2012 Elsevier Inc.tail suspension (Figure S3B). Finally, EAE development was
significantly inhibited when the tail was suspended (Figure 4D).
In normal mice without pathogenic CD4+ T cell transfer, NFkB
activation, which like STAT3 activation is also critical for IL-6
amplifier activation, was enhanced in the blood vessels of the
fifth lumbar cord, but not in those of the first lumbar or cervical
cords (Figure 4E). Tail-suspended mice, however, responded
differently, as NFkB activation was enhanced in vessels of the
cervical cord, but not those of the first or fifth lumbar cords (Fig-
ure 4E). These data strongly suggest sensory nerve activation by
the soleusmuscles plays a role in CCL20 expression in the dorsal
vessels of the fifth lumbar cord prior to the development of auto-
immune diseases that occur froman accumulation of pathogenic
CD4+ T cells. To confirm this, we stimulated soleus muscles
directly by using an electronic stimulator while mice were
suspended from their tails. Electronic stimulations in the soleus
muscles increased CCL20 expressions in the dorsal blood
vessels in a manner dependent on stimulus duration (see the
right four columns in Figure 4A). These stimulations also
increased the number of pathogenic CD4+ T cells in the fifth
lumbar cord (Figure 4B) and c-fos expression in the fifth lumbar
dorsal root ganglia (Figure 4C). All these results are consistent
with regional neural activations via soleus muscle-mediated
sensory nerve activation creating gates for pathogenic CD4+
T cell accumulation into the CNS.
For further validation of our tail suspension model, five addi-
tional experiments were done. In the first, electrically stimulating
the quadriceps, whose afferent nerves come from the third
A C D E F
B
Figure 3. CCL20 Expression Plays a Role in Pathogenic CD4+ T Cell Migration in the Fifth Lumbar Cord
(A) CCL20 mRNA expression in the dorsal blood vessels in each spinal cord was investigated by real time PCR in normal C57BL/6 mice. CCL20 expression in the
fifth lumber cord increased comparing to other cords.
(B) CCL2, CCL3, CCL9, CCL21, CCL24, CX3CL1, CXCL1, CXCL2, CXCL9, and CXCL11 mRNA expression in the dorsal blood vessels of each spinal cord were
investigated by real-time PCR in normal C57BL/6 mice.
(C) Pathogenic CD4+ T cells isolated from EAE mice were intravenously transferred into wild-type C57BL/6 mice in the presence or absence of anti-CCL20
antibody administration (days 0–5 or 8–13 after the pathogenic CD4+ T cell transfer). Relative accumulation of pathogenic CD4+ T cells in the fifth lumbar cord
were investigated with sections from mice 5 days after the pathogenic T cell transfer.
(D and E) Clinical EAE scores of the mice (n = 10 each) described in (C).
(F) CCL20 mRNA expression in the dorsal blood vessels of the fifth lumbar cord, in wild-type C57BL/6 and mutant mice deficient of IL-6 or of gp130 or STAT3 in
their type 1 collagen+ cells. CCL20 expression in the fifth lumber cord decreased in all mutant mice comparing to wild-type ones.
Error bars represent the mean ± SEM, *p < 0.05, **p < 0.01, ***p < 0.005 (A and C–F). Error bars represent the mean ± SD, *p < 0.05, **p < 0.01 (B). See also
Figure S2.lumbar dorsal root ganglia, and the epitrochlearis/triceps brachii,
whose afferent nerves come from between the fifth cervical and
fifth thoracic dorsal root ganglia, caused CCL20 expression to
increase in the third lumbar vessels and between the fifth cervical
and fifth thoracic vessels, respectively (Figure S3C). Similarly,
these stimulations increased cfos expression (Figure S3D). We
next employed a deafferentation method where afferent fibers
of the fifth lumbar dorsal root ganglia were resected to reduce
the soleus muscle response against gravity while only making
minimal changes to body balance (Kawano et al., 2007). We
found CCL20 expression in the fifth lumbar vessels decreased
just like that in the tail suspensionmodel,whileCCL20expression
in the first lumbar vessels were unchanged (Figure S3E). Further-
more, cfos expressiondecreased in dorsal root ganglia of the fifth
lumbar cords (Figure S3F). We employed tail suspensions plus
a casting, as this combination is reported to increase dorsal
root ganglionactivation (Kawanoet al., 2002), finding the increase
in CCL20 expression in the fifth lumbar vessels was even greater
than tail suspension alone (Figure S3G). Finally, we investigated
blood flow speed in blood vessels of the fifth lumbar dorsal
region, bottoms of the forefeet, palms, femoral vessels, brainsurface vessels, portal vein, and intestinal microvessels in normal
and tail suspended mice. In all cases, speeds were comparable
for all investigated regions between the two mouse types except
for the fifth lumbar region (Figure S3H). These results demon-
strate the viability of our tail suspension model and indicate that
regional neural activations create gates for pathogenic CD4+
T cell entry into the CNS by increasing CCL20 expression.
Soleus Muscle-Mediated Sensory Nerve Activation
at Least Partially Enhances CCL20 Expression
in the Fifth Lumbar Cord via Sympathetic Neurons
Finally,weconsidered howsensory nerve activations fromsoleus
muscles change the state of dorsal vessels of the fifth lumbar
cord to cause an accumulation of pathogenic CD4+ T cells.
Continuing the blood flow speed experiments described above,
we found electrically stimulating soleusmuscles can change fifth
lumbar blood flow speed (Figure 5A). Additionally, treatment with
the norepinephrine antagonist atenolol significantly suppressed
CCL20 mRNA expression, NFkB activation, and pathogenic
CD4+ T cell accumulation around these vessels and abrogated
EAE development (Figures 5B–5F). Similar results were obtainedCell 148, 447–457, February 3, 2012 ª2012 Elsevier Inc. 451
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Figure 4. Sensory Nerve Activation via Soleus Muscle Stimulation Is Critical for CCL20 Expression in the Fifth Lumbar Cord and Pathogenic
CD4+ T Cell Accumulation
(A) CCL20 mRNA expression in dorsal blood vessels of the fifth lumbar cord in wild-type C57BL/6 mice with or without tail suspension (TS) in the presence or
absence of soleus muscle electrostimulation (ES).
(B) Accumulation of pathogenic CD4+ T cells in the fifth lumbar cord or spinal cords in the cervical spines of wild-type C57BL/6 mice that received transfusions of
pathogenic CD4+ T cells isolated from EAEmice. Mice were grouped as with or without TS and ES. Relative accumulations were measured from sections 5 days
after the pathogenic T cell transfer.
(C) Top: Histological analysis with frozen sections stained with anti-cFos antibody (cFos). Representative data from the dorsal root ganglion beside the fifth
lumber cords of the mice described in (B) are shown. Green, cFosmolecules; blue, nuclei. Experiments were performed at least three times. Scale bars represent
50 mm. Middle: Quantification of histological analysis (n = 300 cells each). Bottom: c-fos mRNA expression in the dorsal root ganglia of the fifth lumbar cord.
Stimulations lasted 12 hr.
(D) Clinical EAE scores (n = 5 for each group).
(E) NFkB activation monitored by luciferase activity in the dorsal blood vessels of the first lumbar cord (L1), fifth lumbar cord (L5), and spinal cords in the cervical
spines (C1–C7) of C57BL/6 mice transduced with a NFkB reporter with or without TS. NFkB activation in the fifth lumber cord increased comparing to other
lumber cords without tail suspension, while that in the cervical cords increased comparing to other lumber cords after tail suspension. Dorsal blood vessels were
isolated under a stereoscopic microscope.
Error bars represent the mean ± SEM, *p < 0.05, **p < 0.01 (A, B, D, and E). Error bars represent the mean ± SD, **p < 0.01 (C). See also Figure S3.using another norepinephrine antagonist, prazosin (Figure S4).
Furthermore, about 15% of sympathetic nerves in fifth lumbar
spine ganglia expressed c-fosmolecules, while first lumbar spine
ganglia did not, which is consistent with CCL20 expression in
their dorsal vessels (Figure 5G). Consistent with these in vivo
results, norepinephrine enhanced IL-6 amplifier activation based
on IL-6 or CCL20 expression levels in vitro (Figures 5H and 5I).
Taken together, these results indicate that sympathetic nerve
activation induced by soleusmuscles is at least partially involved
in the enhanced expression of chemokines like CCL20 in dorsal
blood vessels, and that this leads to an accumulation of patho-
genic CD4+ T cells in the fifth lumbar cord (Figure 5J). All these
results demonstrate that regional neural activations via the soleus
muscle-mediated sensory nerve enable pathogenic CD4+ T cell
entry into the CNS from adjacent blood vessels.
DISCUSSION
Although it is known that autoimmune diseases can correlate
with neurological states like stress, how neural signals are phys-452 Cell 148, 447–457, February 3, 2012 ª2012 Elsevier Inc.ically transformed into an immune response in the CNS is poorly
understood. In the current study, we describe how regional
neural activations can create gates in specific blood vessels
that allow for immune cell entry into the CNS. We employed
sensory neural activations of the soleus muscles, finding sympa-
thetic nerve activations here lead to excess CCL20 expression in
the fifth lumbar cord in a manner dependent on the activation of
the IL-6 amplifier. This in turn leads to the activation of NFkB and
STAT3 in type 1 collagen+ endothelial cells. Therefore, neuroim-
mune interactions induce regional alterations in blood vessels
and venules such that immune cells can enter the CNS. When
pathogenic helper T cells are in the blood stream, these neuroim-
mune interactions risk the development of autoimmune disease.
IL-6 amplifier activation has been shown to be critical for the
development of autoimmune diseases like EAE and rheumatoid
arthritis (Hirano, 2010; Murakami et al., 2011; Ogura et al., 2008).
We recently proposed a mechanism that depends on local IL-6-
amplifier activation to explain the development of MHC class
II-associated diseases as a four-step model for autoimmune
diseases. This model shows four local events that must occur
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Figure 5. Soleus Muscle-Mediated Sensory Nerve Activation at Least Partially Enhances IL-6 Amplifier Activation via Sympathetic Neurons
(A) Blood flow in the dorsal vessel of the fifth lumbar cord in wild-type C57BL/6 with or without tail suspension (TS) in the presence or absence of soleus muscle
electrostimulation (ES).
(B) CCL20 mRNA expression in vessels from wild-type C57BL/6 mice with or without atenolol treatment.
(C) NFkB activation monitored by luciferase activity in vessels from C57BL/6 mice transduced with a NFkB reporter with or without atenolol treatment.
(D) Pathogenic CD4+ T cells isolated from EAE mice were intravenously transferred into wild-type C57BL/6 mice. Relative accumulation of pathogenic CD4+
T cells in the fifth lumbar cord of wild-type mice with or without atenolol treatment (days 0–5 or 8–13 after the pathogenic CD4+ T cell transfer).
(E and F) Clinical EAE scores (n = 5 for each group).
(G) Top left: Histological analysis using serial frozen sections stained with anti-tyrosine hydroxylase antibody (TH) or anti-cFos antibody (cFos). Sympathetic first
and fifth lumber cords ganglia are shown. Green, TH and cFos, respectively, in the sympathetic ganglion beside the fifth lumber cord; blue, nuclei. Scale bars
represent 50 mm. Representative data are shown. Top right: Histological analysis after double staining with chicken anti-tyrosine hydroxylase antibody (TH, red)
or rabbit anti-cFos antibody (cFos, green). Blue, nuclei. Scale bars represent 25 mm. Bottom: Quantification of histological analysis based serial frozen sections
(top left) (n = 300 cells for each group).
(G–I) IL-6 amplifier activation was enhanced in the presence of norepinephrine. BC1 cells stimulated with human IL-6 plus soluble IL-6 receptor and/or IL-17A for
48 hr in the absence or presence of norepinephrine (G, 10–300 mM; H, 100 mM). Culture supernatants were collected and assessed using an ELISA specific for
mouse IL-6 (H) and CCL20 (I). IL-6 and CCL20 concentrations increased in the presence of norepinephrine in each condition.
(J) Schematic figure of neural activation-induced pathogenic T cell accumulation in the CNS. Neural activation-mediated IL-6 amplifier enhancement in endo-
thelial cells of dorsal blood vessels in the fifth lumbar cord induces CCL20 followed by the accumulation of pathogenic Th17 cells, a critical event for the
development of EAE.
Error bars represent themean ±SEM, *p < 0.05, **p < 0.01, ***p < 0.005 (A–F). Error bars represent themean ±SD, *p < 0.05, **p < 0.01, ***p < 0.005 (G–I). See also
Figure S4.prior to chronic activation of the IL-6 amplifier and subsequent
chronic inflammation in the affected tissue: (1) activation of
CD4+ T cells regardless of the antigen-specificity, (2) triggering
factors for local accumulation of CD4+ T cells, (3) transient acti-
vation of the IL-6 amplifier in local tissues by cytokines from the
CD4+ T cells, and (4) increased sensitivity to the cytokines in
these local tissues (Murakami and Hirano, 2011). Furthermore,
it is likely that each step interacts with the others, the degree
of which varies with the pathogenesis of the disease. Our currentresults lead us to propose that neural activation may contribute
to steps 2 or 4.
Sensory neural activation of the soleus muscles activated
sympathetic neurons. This was followed by CCL20 expression
via IL-6 amplifier activation. That sympathetic nerves are
involved is consistent with other reports in which EAE was
induced by systemic immunization in the presence or absence
of norepinephrine antagonists (Brosnan et al., 1985; Dimitrijevic
et al., 2007). We suspect increased blood flow speed in the fifthCell 148, 447–457, February 3, 2012 ª2012 Elsevier Inc. 453
lumbar cord is a direct or indirect effect of the exercise pressor
reflex, which is an example of sensory neuron stimulation that
leads to sympathetic neuron activation (Kaufman and Hayes,
2002; Smith et al., 2006). Activation of this reflex changes blood
pressure or blood flow via alterations in the blood vessel, partic-
ularly those in muscle (Kaufman and Hayes, 2002; Smith et al.,
2006). However, it is still an open question on how sensory
neurons via the soleus connect to sympathetic neurons and
the sympathetic ganglion. We suspect this connection occurs
at the dorsal root ganglia of the fifth lumbar cord, since even
though sympathetic axons exist in normal dorsal root ganglia
they increase in number following a sensory neuron injury (Xie
et al., 2010).
Unlike mice, patients suffering from MS do not always display
symptoms in their lower body. Instead,MS symptoms are gener-
ally isolated in the upper body, particularly the thoracic cord and
cerebrum. This difference might be due to different sites for the
pathogenic CD4+ T cell accumulation that follows local inflam-
mation. Because different regional neural activation–mediated
CCL20 expression were induced by stimulating several muscles
such as the soleus muscles, the quadriceps, and epitrochlearis/
triceps brachii (Figure 4A and Figures S3C and S3D), we believe
that excess sensory stimulations in other regions like the hands,
fingers, and optic nerves, and even less visceral locations like
chronic mental stress may affect MS symptoms by promoting
excess neural activations and IL-6 amplifier activation in vessels
of the thoracic cord and/or cerebrum. Such a theory could also
help explain the effects of acupuncture, which involves directly
stimulating peripheral nerves to change body homeostasis
(Longhurst, 2010). We therefore hypothesize that acupuncture
effects may arise by changing the blood vessel status of the
target organ.
In the rat transfer models, pathogenic T cells migrate to the
spleen prior to entering the CNS (Matsumoto et al., 1988; Pan-
itch, 1980). That we found pathogenic CD4+ T cells negligibly
accumulate in the fifth lumbar cord by day 4 is consistent with
this. However, we also found that the fifth lumbar cord shows
chemokine expression even in the steady state (Figures 3A
and 3B). Such an observation suggests that the transferred path-
ogenic CD4+ T cells need not wait until day 4, as they can instead
enter the spinal cord using this axis directly. One reason we did
not find earlier T cell accumulation may be that the pathogenic
CD4+ T cells express relatively low levels of CCR6 after in vitro
culture. That would explain why CCR6 expression levels
increased following pathogenic CD4+ T cell division in the
superficial lymph nodes, aortal lymph nodes, mescenteric lymph
nodes, and spleens on day 4 after the transfer (Figure S5) and
that deficientCCR6 in pathogenic CD4+ T cells suppressed early
T cell entry into the CNS (Figure S2A). Additionally, CCL20 or
adrenergic inhibition reduced EAE development, particularly
for the first 5 days after pathogenic CD4+ T cell transfer (Figures
3D and 5E), while anti-CCL20 or an adrenergic receptor inhibitor
from day 8 after the pathogenic CD4+ T cell transfer upon indica-
tions of slight tail polarization (Figures 3E and 5F). Theses results
suggest that both blockades have partial therapeutic effects for
multiple sclerosis.
It has been observed that the expression of chemokines like
CCL20 in the dorsal vessels of the fifth lumbar cord in response454 Cell 148, 447–457, February 3, 2012 ª2012 Elsevier Inc.to soleus muscle stimulation can facilitate immunity against
pathogenic invasions or latent infectious states in the CNS
(McGavern and Kang, 2011; Salinas et al., 2010). Consistent
with this, we found the expression of all observed chemokines
increased there. This increase could also signal the recruitment
of other cell populations, including nonimmune cells as well as
other neural precursor cells including microglia ones. Therefore,
regional neural activations may maintain homeostasis of the
CNS environment by regulating the entry of various cell types
from the blood. These phenomena then may suggest the impor-
tance of the IL-6 amplifier, a synergistic signal between NFkB
and STAT3, for the accumulation of various cell types including
pathogenic T cells by creating a gateway to CNS that depends
on various sets of chemokine expressions.
To summarize, we describe an entry site at the dorsal blood
vessels of the fifth lumbar cord for blood cells including patho-
genic CD4+ T cells into the CNS. Mechanistic experiments
demonstrated that CCL20, which we found to be positively regu-
lated by sensory nerve activation via antigravity soleus muscles,
plays a role in this accumulation, and that its expression risks the
development of autoimmune diseases when pathogenic CD4+
T cells are present in the blood stream. More importantly,
sensory nerve activation enhances CCL20 expression in these
dorsal blood vessels via the activation of sympathetic neurons,
meaning neural activation can be transformed into an inflamma-
tory signal that leads to autoimmune disease. The location of this
neuroinflammatory transformation may prove a valuable thera-
peutic target for various neuroimmune diseases including auto-
immune and inflammatory diseases and is therefore worthy of
more study.
EXPERIMENTAL PROCEDURES
Mouse Strains
C57BL/6 mice were purchased from Japan SLC. IL-6-deficient mice were
provided by Dr. M. Kopf (Max Planck Institute of Immunobiology, Germany)
and backcrossed with C57BL/6 mice more than ten times. Type I collagen-
Cre mice were provided by Dr. G. Karsenty (Baylor College of Medicine,
Houston, TX) and crossed with STAT3flox/flox mice (provided by Dr. S. Akira,
Osaka University, Japan) (Takeda et al., 1998) and gp130flox/flox mice (Betz
et al., 1998). Tie2-Cre mice were provided by Dr. H. Kawamoto (RIKEN
Research Center for Allergy and Immunology, Yokohama, Japan). IL-17A-defi-
cient (Iwakura and Ishigame, 2006), NFkB reporter (Sadikot and Blackwell,
2008), CCR6-deficient (Varona et al., 2001), and IFNg-deficient (Ueda et al.,
2006) mice in a C57BL/6 background were also used. All mice were main-
tained under specific pathogen-free conditions according to the protocols
of the Osaka University Medical School. All animal experiments were
performed following the guidelines of the Institutional Animal Care and Use
Committees of the Graduate School of Frontier Bioscience and Graduate
School of Medicine, Osaka University.
Passive Transfer of Pathogenic CD4+ T Cells to Induce EAE
EAE induction was performed as described previously (Ogura et al., 2008). In
brief, C57BL/6 mice and IL-17A-deficient, IFNg-deficient mice were injected
with a MOG (35–55) peptide (synthesized by Sigma) in complete Freund’s
adjuvant (Sigma-Aldrich, Tokyo) at the base of the tail on day 0 followed by
intravenous injection of pertussis toxin (Sigma-Aldrich, Tokyo) on days 0, 2,
and 7. On day 10, CD4+ T cells from the resulting mice were sorted with
anti-CD4 microbeads (Milteny, Tokyo). The resulting CD4+ T cell-enriched
population (4 3 106 cells) was cocultured with rIL-23 (10 ng/ml; R&D, Minne-
apolis) in the presence ofMOGpeptide-pulsed bonemarrow-derived dendritic
cells (53 105) for 2 days. Cells (1.53 107) were then injected intravenously into
wild-type or mutant mice. Clinical scores were measured as described previ-
ously (Ogura et al., 2008).
Mononuclear Cell Isolation from Spinal Cords
Mononuclear cells from spinal cords were isolated after cardiac perfusion with
PBS as described previously (Sawa et al., 2009).
Frozen Section Preparations and Histological Analysis
Spines were harvested and fixed in 4% paraformaldehyde for 12 hr and then
displaced with 10% sucrose solution for 12 hr, 20% sucrose solution for
12 hr, and finally 30% sucrose solution for 12 hr (total 48 hr). The resulting
spines were embedded in SCEM compound (SECTION-LAB, Japan). The
cut surface was covered with an adhesive film (Cryofilm type IIC9,
SECTION-LAB, Japan) and frozen sections (10 mm) were prepared with a
macrotome (CM3600XP Leica Microsystems, Germany) according to a
method described previously (Kawamoto, 2003). The resulting sections were
stained with hematoxylin/eosin and analyzed with a BZ-9000 microscope
(KEYENCE).
Intracellular Cytokine Staining
The number of Th17 cells in vivo was determined as previously described
(Nishihara et al., 2007). In brief, T cells from spinal cords were stimulated
with MOG peptide presented on LPS-stimulated bone marrow-derived
dendritic cells in the presence of GolgiPlug (BD Biosciences, Tokyo) for 6 hr.
Intracellular IL-17A and IFN-g were labeled with anti-IL-17A and anti-IFN-g
antibodies after surface staining, fixation, and permeabilization.
Antibodies and Reagents
The following antibodies were used for flow cytometry analysis: APC-conju-
gated anti-IFN-g (eBioscience, San Diego) and control IgG1k (eBioscience,
San Diego); FITC-conjugated anti-CD8 (eBioscience, San Diego), anti-CD19
(eBioscience, San Diego), anti-B220 (BD PharMingen, Tokyo), anti-NK1.1
(eBioscience, San Diego), and anti-I-A/I-E (BioLegend, Tokyo); PE-conjugated
anti-IL-17A (eBioscience, San Diego), control IgG2a (eBioscience, San Diego),
and anti-I-A/I-E (BioLegend, Tokyo); PE-Cy5-conjugated anti-CD4 (BioLe-
gend, Tokyo); PE-Cy7-conjugated anti-CD4 (BioLegend, Tokyo); Pacific
Blue-conjugated anti-CD44 (eBioscience, San Diego) and Streptavidin
(Invitrogen, Tokyo); and Biotin-conjugated anti-CD90.2 (eBioscience, San
Diego). The following antibodies were used for immunohistochemistry: anti-
phospho-STAT3 (Tyr705, D3A7) (Cell signaling), anti-tyrosine hydroxylase
(Abcam, Tokyo), anti-cFos (Sigma, Tokyo), and control rabbit IgG (DA1E)
(Cell Signaling, Tokyo); and Alexa Fluor 488 goat anti-rabbit IgG (H + L)
and Alexa 647 goat anti-chicken IgG (Invitrogen, Tokyo). The following
antibodies were used for in vivo neutralization: purified anti-mouse CCL20
mAb (R&D, Minneapolis). Atenolol and prazosin were purchased from
Sigma-Aldrich, Tokyo. The VECTASTAIN Elite ABC Rabbit IgG Kit and the
DAB Peroxidase Substrate kit were purchased from Vector Laboratories,
Burlingame.
ELISA
IL-6 and IL-17A levels in serum or cell cultures supernatant were determined
with ELISA kits (BD PharMingen, Tokyo; eBioscience, San Diego; or R&D, Min-
neapolis). CCL20 levels in cell cultures supernatant were determined using
ELISA kits (R&D, Minneapolis).
Flow Cytometry
For cell surface labeling, 106 cells were incubated with fluorescence-conju-
gated antibodies for 30 min on ice. The cells were then analyzed with cyan
flow cytometers (Beckman Coulter, Tokyo). The collected data were analyzed
with Summit software (Beckman Coulter, Tokyo) and/or Flowjo software (Tree
Star, Ashland).
Laser Microdissection
Approximately 100 frozen sections (15 mm) were fixed with acetic acid/ethyl
alcohol (1:19) for 15 min followed by PBS washing for 10 min. Tissues around
the dorsal blood vessels were collected by a laser microdissection device,
DM6000B (Leica, Tokyo), and prepared for total RNA measurements by theGenElute Mammalian Total RNA kit (Sigma-Aldrich, Tokyo) and DNase I
(Sigma-Aldrich, Tokyo).
Real-Time PCRs
A GeneAmp 5700 sequence detection system (ABI, Warrington) and SYBER
green PCR Master Mix (Sigma-Aldrich, Tokyo) were used to quantify CCL20
mRNA and HPRT mRNA levels. The PCR primer pairs used for real-time
PCRs were as follows: mouse HPRT primers, 50-GATTAGCGATGATGAACCA
GGTT-30 and 50-CCTCCCATCTCCTTCATGACA-30; mouse CCL20 primers,
50-CGACTGTTGCCTCTCGTACA-30 and 50-GAGGAGGTTCACAGCCCTTT-30;
mouse CCL2 primers, 50- CCGGCTGGAGCATCCACGTGT-30 and 50- TGGGG
TCAGCACAGACCTCTCTCT-30; mouse CXCL1 primers, 50- CACAGGGGCGC
CTATCGCCAA-30 and 50- CAAGGCAAGCCTCGCGACCAT-30; mouse CXCL2
primers, 50- ACCCCACTGCGCCCAGACAGAA-30 and 50- AGCAGCCCAGGC
TCCTCCTTTCC-30; mouse CX3CL1 primers, 50-ACGAAATGCGAAATCATG
TGC-30 and 50-CTGTGTCGTCTCCAGGACAA-30; mouse CCL3 primers, 50-TG
TACCATGACACTCTGCAAC-30 and 50-CAACGATGAATTGGCGTGGAA-30;
mouse CCL9 primers, 50-CCCTCTCCTTCCTCATTCTTACA-30 and 50-AGTCT
TGAAAGCCCATGTGAAA-30; mouse CCL21 primers, 50-GGGTCAGGACTGC
TGCCTTA-30 and 50-CGGGATGGGACAGCCTAAA-30; mouse CCL24 primers,
50-CCAAGAAGGGCCATAAGATCTG-30 and 50-GCCCCTTTAGAAGGCTGG
TT-30; mouse CXCL9 primers, 50-TCCTTTTGGGCATCATCTTCC-30 and 50-
TTTGTAGTGGATCGTGCCTCG-30; mouse CXCL11 primers, 50-GGCTTCCT
TATGTTCAAACAGGG-30 and 50-GCCGTTACTCGGGTAAATTACA-30; and
mouse c-fos primers, 50-CGGGTTTCAACGCCGACTA-30 and 50-TTGGCACT
AGAGACGGACAGA-30. The conditions for real-time PCR were 40 cycles at
94C for 15 s followed by 40 cycles at 60C for 60 s. The relative mRNA expres-
sion levels were normalized to HPRT mRNA levels.
Hindlimb Suspension
Hindlimb suspension was performed as described previously (Kawano et al.,
2007; Ohira et al., 2002). In brief, strips of sticky tape (about 5 mm wide and
3 cm long) with good cushion were placed longitudinally on the dorsal and
ventral sides of the midtail of the hindlimb-unloaded mouse. These strips
were further surrounded cross-sectionally by another strip. Strips were
adhesed loosely so as to keep the blood flow intact. A string was inserted
through the gap between the tail and tape and fastened to the roof of the
cage at a height that allowed the forelimbs to support the body weight and
prevent the hindlimbs from touching any part of the cage. Amouse could reach
food and water freely by using its forelimbs. The attachment to the tail was
changed each week so as not to inhibit tail growth and blood flow.
Electro Stimulations
In some experiments, hindlimb suspended mice were electrostimulated for
12 hr through the soleus muscle with electrical stimulators (Nippon Koden,
Tokyo and Unique Medical, Osaka) at 0.1 mA and 1–8 ms random intervals.
Electrostimulations were done for 1 day when investigating pathogenic CD4+
T cell migration and two days when measuring CCL20 mRNA expression.
Anti-CCL20 Antibody, Atenolol Treatment, and Prazosin Treatment
Anti-CCL20 antibody (200 mg/mouse) or atenolol (500 mg/mouse) was interper-
itoneally injected into C57BL/6 mice (6–8 weeks old) for 5 days in which path-
ogenic CD4+ T cells were transferred. Atenolol (500 mg/mouse) or prazosin
(500 mg/mouse) was injected into wild-type C57BL/6 mice (6–8 weeks old)
for 5 days without the pathogenic CD4+ T cell transfer.
Luciferase Assay
Blood vessels from the dorsal side of the fifth lumbar cord or first lumbar cord
were harvested. Proteins were collected using a Luciferase Reporter Assay kit
(Promega, Tokyo) and total protein amount was adjusted. Luciferase activities
were measured by a Luciferase detection device (Promega, Tokyo).
Blood Flow Analysis
Blood flow volume was measured in blood vessels from the dorsal side of the
fifth lumbar cord in C57BL/6 mice (6–8 weeks old) in the presence or absence
of tail-suspensions and/or electrostimulations with Omegazone OZ-1 (Omega
wave, Tokyo).Cell 148, 447–457, February 3, 2012 ª2012 Elsevier Inc. 455
Statistical Analysis
Student’s t tests (two-tailed) and ANOVA tests were used for the statistical
analysis of differences between two groups and that of differences between
more than two groups, respectively.SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
article online at doi:10.1016/j.cell.2012.01.022.
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